Involvement of SLP-65 and Btk in tumor suppression and malignant transformation of pre-B cells
- PMID: 16300960
- DOI: 10.1016/j.smim.2005.10.002
Involvement of SLP-65 and Btk in tumor suppression and malignant transformation of pre-B cells
Abstract
Signals from the precursor-B cell receptor (pre-BCR) are essential for selection and clonal expansion of pre-B cells that have performed productive immunoglobulin heavy chain V(D)J recombination. In the mouse, the downstream signaling molecules SLP-65 and Btk cooperate to limit proliferation and induce differentiation of pre-B cells, thereby acting as tumor suppressors to prevent pre-B cell leukemia. In contrast, recent observations in human BCR-ABL1(+) pre-B lymphoblastic leukemia cells demonstrate that Btk is constitutively phosphorylated and activated by the BCR-ABL1 fusion protein. As a result, activated Btk transmits survival signals that are essential for the transforming activity of oncogenic Abl tyrosine kinase.
Similar articles
-
Bruton's tyrosine kinase cooperates with the B cell linker protein SLP-65 as a tumor suppressor in Pre-B cells.J Exp Med. 2003 Jul 7;198(1):91-8. doi: 10.1084/jem.20030615. Epub 2003 Jun 30. J Exp Med. 2003. PMID: 12835482 Free PMC article.
-
The BCR-ABL1 kinase bypasses selection for the expression of a pre-B cell receptor in pre-B acute lymphoblastic leukemia cells.J Exp Med. 2004 Mar 1;199(5):673-85. doi: 10.1084/jem.20031637. J Exp Med. 2004. PMID: 14993251 Free PMC article.
-
Pre-B-cell leukemias in Btk/Slp65-deficient mice arise independently of ongoing V(D)J recombination activity.Leukemia. 2011 Jan;25(1):48-56. doi: 10.1038/leu.2010.246. Epub 2010 Oct 29. Leukemia. 2011. PMID: 21030983
-
Dual role of the adaptor protein SLP-65: organizer of signal transduction and tumor suppressor of pre-B cell leukemia.Immunol Res. 2006;34(2):143-55. doi: 10.1385/IR:34:2:143. Immunol Res. 2006. PMID: 16760574 Review.
-
The pre-BCR checkpoint as a cell-autonomous proliferation switch.Trends Immunol. 2004 May;25(5):249-56. doi: 10.1016/j.it.2004.02.011. Trends Immunol. 2004. PMID: 15099565 Review. No abstract available.
Cited by
-
The Phospholipase Cγ2 Mutants R665W and L845F Identified in Ibrutinib-resistant Chronic Lymphocytic Leukemia Patients Are Hypersensitive to the Rho GTPase Rac2 Protein.J Biol Chem. 2016 Oct 14;291(42):22136-22148. doi: 10.1074/jbc.M116.746842. Epub 2016 Aug 19. J Biol Chem. 2016. PMID: 27542411 Free PMC article.
-
Requirement of phosphatidylinositol(3,4,5)trisphosphate in phosphatidylinositol 3-kinase-induced oncogenic transformation.Mol Cancer Res. 2009 Jul;7(7):1132-8. doi: 10.1158/1541-7786.MCR-09-0068. Epub 2009 Jul 7. Mol Cancer Res. 2009. PMID: 19584261 Free PMC article.
-
Ibrutinib inhibits pre-BCR+ B-cell acute lymphoblastic leukemia progression by targeting BTK and BLK.Blood. 2017 Mar 2;129(9):1155-1165. doi: 10.1182/blood-2016-06-722900. Epub 2016 Dec 28. Blood. 2017. PMID: 28031181 Free PMC article.
-
Development of acute lympboblastic leukemia in a patient with increased hematogones after toxic bone marrow damage.Int J Clin Exp Pathol. 2010 Jan 30;3(3):310-2. Int J Clin Exp Pathol. 2010. PMID: 20224729 Free PMC article.
-
Physical and functional characterization of the genetic locus of IBtk, an inhibitor of Bruton's tyrosine kinase: evidence for three protein isoforms of IBtk.Nucleic Acids Res. 2008 Aug;36(13):4402-16. doi: 10.1093/nar/gkn413. Epub 2008 Jul 2. Nucleic Acids Res. 2008. PMID: 18596081 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous